Effect of anticoagulation on blood membrane interactions during hemodialysis.
about
Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.Essentials of anticoagulation in hemodialysis.Citrate anticoagulation during post-dilution hemodiafiltration with a high cut-off (Theralite) membrane.What are the anticoagulation options for intermittent hemodialysis?Alternatives to standard unfractionated heparin for pediatric hemodialysis treatmentsAdvances in continuous renal replacement therapy: citrate anticoagulation update.The rationale for the use of low molecular weight heparin for hemodialysis treatments.Outside-In Hemofiltration for Prolonged Operation without CloggingA multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane studyCitrate Pharmacokinetics in Critically Ill Patients with Acute Kidney InjuryCalcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges.Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations.Effect of Heparin on Coagulation Tests: A Comparison of Continuous and Bolus Infusion in Haemodialysis Patients.Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytesEfficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipmentCitrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation.A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System.Is Regional Citrate Anticoagulation the Future of Hemodialysis?In vitro and in vivo study of hazardous effects of Ag nanoparticles and Arginine-treated multi walled carbon nanotubes on blood cells: application in hemodialysis membranes.Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure.Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood.Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial.Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.Influence of different heparin concentrations on the results of in vitro investigations in plasmaseparation technology using capillary membrane filters.Treatment Efficacy and Safety During Plasma Exchange With Citrate Anticoagulation: A Randomized Study of 4 Versus 15% Citrate.Micro-computed tomography for the quantification of blocked fibers in hemodialyzers.Citrate Extended High Cut-Off Hemodiafiltration for Renal Recovery in Patients With Multiple Myeloma.Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.Citrate anticoagulation using ACD solution A during long-term haemodialysis.Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup.Good Tolerance of Citrate Accumulation due to Plasma Exchange among Patients with Acute-on-Chronic Liver Failure: A Prospective, Observational Study.
P2860
Q33366848-ECB8D0A0-F045-4372-9B66-ACA1A1BC2DF0Q33374743-83E2DE05-0E21-4B19-A2C4-BA44A7E00FBAQ33395569-E3F57C5F-DC5B-447F-9BF9-7CD7E6A444C9Q33396089-4B633B59-836A-4E1F-99F7-9E3F5B8AE537Q33399961-0D3ED844-38B4-4D8D-8C90-EDF72ED0EB4AQ33403996-B9BDCDE4-FC7E-4BA2-A503-0BB5F55A52EEQ33410982-E8540A9E-F620-49F2-AF20-2B70129D7CAEQ33935592-92275337-7589-4B38-B4C3-0EC6F48DB8C0Q34320163-BF81D75C-68E2-4F7B-871B-A023A38CEE6BQ34792965-DD776D7B-2F2A-47E5-8A0B-6D8098B736F6Q36234783-E3F6B4B9-6F76-44B0-B52A-E7C19703CB9CQ36609871-3A044161-51BD-424D-AEEB-DE7167444286Q36708561-389DDFD5-604D-4516-A4C6-2AACAE70B55AQ37132012-21C66951-B9E1-450E-921E-F2639B66D7FCQ37212336-5B69BE06-72FF-4AF5-AAC3-64F0F6010C18Q37231751-6D7B56AA-16D8-4534-94DC-10B108EEBE8BQ38460284-80C2EEBD-F851-42F6-9724-805BB41825CDQ38851933-CF8C8E6F-C4D2-4AA1-8275-07941F45FBC4Q39037864-D80F8964-6504-47B6-9789-74B611942B12Q39369437-3D6B82C5-DF49-458E-ABE2-F4E824D98B73Q42200738-01C596BA-FBB6-48F1-A23E-2AA2B282C21AQ43108541-2B3F2CD6-2AE4-4908-92A5-FA18E8C4A758Q46556703-2C092E14-D7F3-4370-A8D8-09C76170B546Q47808732-B38C9EA7-AEB7-4676-91EC-85B475AF572AQ48134334-F1AC709E-5EBA-4AC9-920C-71AE0EB155B1Q49026680-64378225-5714-4717-ADBE-8D9A83E161EFQ50796606-1F469A33-8DDC-46C6-B3CD-166ADCAD49D4Q51282848-93E4CE26-38CE-4A16-A6C9-14AD72761C44Q51640125-D3093206-6BCF-4358-9904-FAAE61655D88Q55312001-0DB47189-80DA-4F7C-BCC3-1D80DD7D1B19Q55312762-5733C734-27C2-430D-8262-0374A1A6B316
P2860
Effect of anticoagulation on blood membrane interactions during hemodialysis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effect of anticoagulation on blood membrane interactions during hemodialysis.
@ast
Effect of anticoagulation on blood membrane interactions during hemodialysis.
@en
type
label
Effect of anticoagulation on blood membrane interactions during hemodialysis.
@ast
Effect of anticoagulation on blood membrane interactions during hemodialysis.
@en
prefLabel
Effect of anticoagulation on blood membrane interactions during hemodialysis.
@ast
Effect of anticoagulation on blood membrane interactions during hemodialysis.
@en
P2093
P1433
P1476
Effect of anticoagulation on blood membrane interactions during hemodialysis.
@en
P2093
R Hofbauer
R Oberbauer
S Kapiotis
P304
P356
10.1046/J.1523-1755.1999.00671.X
P407
P577
1999-10-01T00:00:00Z
P5875
P6179
1047524925